CD8A and neoplasm: Furthermore, we confirmed that non-DCs also potentiated DC-mediated expansion of tumor-reactive (MiHA) CD8+ T cells in a clinically relevant context using patient-derived HA-1-specific CD8+ T cells of two independent patients (Fig. 4f).